1Veldhuis J D, Pincus S M. Disruption of the synchronous secretion of Leptin, LH, and ovarian androgens in nonobese adolescents with the poly cystic ovarian syndrome. J Clin -Endocrinol Metab. 2001 Aug, 86(8):3772.
2Solomon CG. The epidemiology of poly - cystic ovary syndrome: prealence and associated disease risk. Endocrinol Metab Clin North Am.1999, 28:247.
3Maliqueo M, Piwonka V, Perez Bravo F, et al. Evaluation of acute effect of GnRH administration on leptin secretion in normal and hyperandrogenic women. Med Chil. 2000, 128(5) :676.
4Yildirim B, Sabir N, Kaleli B. Relation of intra- abdominal fat distribution to metabolic disorders in nonobese patients with poly cystic ovary syndrome. Fertil - Steril. 2003 Jun, 79(6) :1358.
5Greisen S, Ledet T, Moller M, et al. Effects of leptin on basal and FSH stimulated steroidogenesis in human granulose luteal cells. Acta Obstet Gynecol Scand. 2000, 79(11) :931.
5j Lee MT,Anderson E,Lee GY.Changes in ovarian morphology and serum hormones in the rat after treatment with dehydroepiandrosterone[J].Anat Rec,1991,231:185-192.
6Anderson E,Lee GY,Obrein K.Polycystic ovarian condition in the dehydroepiandrosterone treated rat model:hyperandrogenism and the resumption of meiosis are major initial events associated with cystogensis of antral follicle[J].Anat Rec,1997,249:44-53.
